CPC A61M 35/003 (2013.01) [A61F 5/41 (2013.01); A61F 2005/411 (2013.01); A61F 2005/418 (2013.01)] | 11 Claims |
1. A system for the treatment of a pelvic disorder comprising:
(a) a composition comprising magnetic particulates which are either (i) physically associated with a cell population (ii) or physically associated with a drug or a biologic agent, or both (i) and (ii), which are configured for injection into a pelvic tissue; and
(b) a device configured to be associated with a pelvic anatomical structure, the device having a platform pivotally coupled to a roller and being capable of providing a magnetic field which influences movement of the magnetic particulates and associated cell population, drug, or biologic agent within the pelvic tissue.
|